Dramatic response of metaplastic breast cancer to chemo-immunotherapy

被引：0
|
作者：
Sylvia Adams
机构：
[1] New York University School of Medicine,
[2] Perlmutter Cancer Center,undefined
来源：
npj Breast Cancer | / 3卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Frequent overexpression of programmed death-ligand 1 has recently been demonstrated in metaplastic breast cancer, which is a rare breast cancer subtype with limited treatment options. This report describes the clinical course of a patient with metastatic metaplastic breast cancer who had a remarkable response to anti-programmed death-1 therapy with pembrolizumab in combination with nab-paclitaxel. Tissue correlates are presented including tumor-infiltrating lymphocytes and high-programmed death-ligand 1 expression in the tumor.
引用
收藏
相关论文
共 50 条
  • [1] Dramatic response of metaplastic breast cancer to chemo-immunotherapy
    Adams, Sylvia
    NPJ BREAST CANCER, 2017, 3
  • [2] Prospective evaluation of pathologic response with neoadjuvant chemo-immunotherapy in metaplastic breast cancer
    Abuhadra, Nour
    Chen, Yuan
    Plitas, George
    Razavi, Pedram
    Pareja, Fresia
    Reis-Filho, Jorge S.
    Wen, Hannah Yong
    Khan, Atif J.
    Traina, Tiffany A.
    Downs-Canner, Stephanie
    Robson, Mark E.
    Norton, Larry
    Montagna, Giacomo
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] ADJUVANT CHEMO-IMMUNOTHERAPY IN BREAST-CANCER
    JORGENSEN, OG
    GUNDERSEN, S
    ACTA CHIRURGICA SCANDINAVICA, 1981, : 109 - 109
  • [4] Chemo-immunotherapy and chemo-adoptive immunotherapy of cancer
    Gomez, GG
    Hutchison, RB
    Kruse, CA
    CANCER TREATMENT REVIEWS, 2001, 27 (06) : 375 - 402
  • [5] An increase in eosinophils is associate with response to chemo-immunotherapy in metastatic triple negative breast cancer
    Ghebeh, Hazem
    Elshenawy, Mahmoud A.
    Al-Sayed, Adher
    Al-Tweigeri, Taher
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (01)
  • [6] CHEMOTHERAPY VERSUS CHEMO-IMMUNOTHERAPY IN ADVANCED BREAST-CANCER
    MUSS, HB
    COOPER, MR
    RICHARDS, F
    WHITE, DR
    SPURR, CL
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 356 - 356
  • [7] CHEMO-IMMUNOTHERAPY
    BUCHANAN, JG
    CASEY, TP
    NEW ZEALAND MEDICAL JOURNAL, 1974, 79 (511) : 803 - 804
  • [8] INITIAL CHEMO-IMMUNOTHERAPY IN INFLAMMATORY CARCINOMA OF THE BREAST
    ZYLBERBERG, B
    SALATBAROUX, J
    RAVINA, JH
    DORMONT, D
    AMIEL, JP
    DIEBOLD, P
    IZRAEL, V
    CANCER, 1982, 48 (07) : 1537 - 1543
  • [9] Complete Response of Chemo-Refractory Metastatic Metaplastic Breast Cancer to Paclitaxel-Immunotherapy Combination
    Al Sayed, Adher D.
    Elshenawy, Mahmoud A.
    Tulbah, Asma
    Al-Tweigeri, Taher
    Ghebeh, Hazem
    AMERICAN JOURNAL OF CASE REPORTS, 2019, 20 : 1630 - 1635
  • [10] CHEMO-IMMUNOTHERAPY WITH OR WITHOUT OOPHORECTOMY IN PREMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER
    YAP, HY
    HORTOBAGYI, GN
    BLUMENSCHEIN, GR
    TASHIMA, CK
    BUZDAR, AU
    KRUTCHIK, AN
    BENJAMIN, RS
    GUTTERMAN, JU
    BODEY, GP
    JOURNAL OF SURGICAL ONCOLOGY, 1979, 12 (04) : 333 - 341
12345